ID: ALA3764379

Max Phase: Preclinical

Molecular Formula: C23H39NO19

Molecular Weight: 633.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)[C@@H]2O)(C(=O)O)C[C@@H]1O

Standard InChI:  InChI=1S/C23H39NO19/c1-6(28)24-11-7(29)2-23(22(37)38,42-18(11)12(31)8(30)3-25)43-19-13(32)9(4-26)40-21(16(19)35)41-17-10(5-27)39-20(36)15(34)14(17)33/h7-21,25-27,29-36H,2-5H2,1H3,(H,24,28)(H,37,38)/t7-,8+,9+,10+,11+,12+,13-,14+,15+,16+,17+,18+,19-,20+,21-,23-/m0/s1

Standard InChI Key:  CILYIEBUXJIHCO-UITFWXMXSA-N

Associated Targets(Human)

Sialic acid-binding Ig-like lectin 7 83 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-8 303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 633.55Molecular Weight (Monoisotopic): 633.2116AlogP: -8.22#Rotatable Bonds: 11
Polar Surface Area: 335.08Molecular Species: ACIDHBA: 18HBD: 13
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.84CX Basic pKa: CX LogP: -7.11CX LogD: -10.60
Aromatic Rings: 0Heavy Atoms: 43QED Weighted: 0.10Np Likeness Score: 1.76

References

1. Matsubara T, Onishi A, Yamaguchi D, Sato T..  (2016)  Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.,  24  (5): [PMID:26833245] [10.1016/j.bmc.2016.01.039]
2. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R..  (2017)  Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion.,  60  (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111]
3. Patel B,Kishor C,Houston TA,Shatz-Azoulay H,Zick Y,Vinik Y,Blanchard H.  (2020)  Rational Design and Synthesis of Methyl-β-d-galactomalonyl Phenyl Esters as Potent Galectin-8N Antagonists.,  63  (20.0): [PMID:32809817] [10.1021/acs.jmedchem.0c00602]

Source